Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventriculoperitoneal Shunt | 2 | 2015 | 10 | 1.010 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2020 | 13 | 0.850 |
Why?
|
| Rhabdoid Tumor | 1 | 2020 | 3 | 0.750 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2020 | 34 | 0.710 |
Why?
|
| Intracranial Hemorrhages | 2 | 2016 | 14 | 0.670 |
Why?
|
| Orbital Cellulitis | 1 | 2016 | 2 | 0.570 |
Why?
|
| Empyema, Subdural | 1 | 2016 | 4 | 0.570 |
Why?
|
| Catheter Obstruction | 1 | 2016 | 3 | 0.560 |
Why?
|
| Epidermal Cyst | 1 | 2016 | 6 | 0.540 |
Why?
|
| Postoperative Hemorrhage | 1 | 2016 | 25 | 0.540 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2016 | 43 | 0.540 |
Why?
|
| Thrombolytic Therapy | 1 | 2016 | 56 | 0.530 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 58 | 0.530 |
Why?
|
| Abducens Nerve Diseases | 1 | 2015 | 3 | 0.530 |
Why?
|
| Calcinosis | 1 | 2016 | 48 | 0.520 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 67 | 0.510 |
Why?
|
| Dermoid Cyst | 1 | 2015 | 4 | 0.510 |
Why?
|
| Central Nervous System Cysts | 1 | 2015 | 6 | 0.510 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2015 | 4 | 0.510 |
Why?
|
| Emergency Treatment | 1 | 2014 | 3 | 0.490 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2014 | 2 | 0.480 |
Why?
|
| Catheters, Indwelling | 1 | 2014 | 26 | 0.480 |
Why?
|
| Intestinal Obstruction | 1 | 2014 | 12 | 0.480 |
Why?
|
| Hydrocephalus | 1 | 2014 | 28 | 0.480 |
Why?
|
| Ischemia | 1 | 2014 | 27 | 0.480 |
Why?
|
| Intestine, Small | 1 | 2014 | 34 | 0.470 |
Why?
|
| Fever | 1 | 2014 | 40 | 0.470 |
Why?
|
| Hypothermia, Induced | 1 | 2011 | 22 | 0.390 |
Why?
|
| Brain Injuries | 1 | 2011 | 48 | 0.390 |
Why?
|
| Humans | 21 | 2021 | 29893 | 0.380 |
Why?
|
| Encephalocele | 2 | 2021 | 26 | 0.360 |
Why?
|
| Female | 12 | 2021 | 16476 | 0.320 |
Why?
|
| Cerebrospinal Fluid Leak | 2 | 2019 | 18 | 0.320 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2019 | 1247 | 0.310 |
Why?
|
| Equipment Failure | 2 | 2015 | 52 | 0.250 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2019 | 778 | 0.250 |
Why?
|
| Brain | 2 | 2014 | 1727 | 0.250 |
Why?
|
| Treatment Outcome | 6 | 2019 | 3558 | 0.220 |
Why?
|
| Glioma | 2 | 2019 | 52 | 0.220 |
Why?
|
| Radiology | 1 | 2021 | 22 | 0.190 |
Why?
|
| Adult | 7 | 2021 | 8774 | 0.180 |
Why?
|
| Semicircular Canals | 1 | 2019 | 5 | 0.170 |
Why?
|
| Cranial Fossa, Middle | 1 | 2019 | 6 | 0.170 |
Why?
|
| Temporal Bone | 1 | 2019 | 10 | 0.170 |
Why?
|
| Brain Stem Neoplasms | 1 | 2019 | 3 | 0.170 |
Why?
|
| Craniotomy | 1 | 2019 | 24 | 0.170 |
Why?
|
| Astrocytoma | 1 | 2019 | 26 | 0.170 |
Why?
|
| Brain Stem | 1 | 2019 | 25 | 0.170 |
Why?
|
| SEER Program | 1 | 2019 | 38 | 0.170 |
Why?
|
| Decompression, Surgical | 1 | 2020 | 144 | 0.160 |
Why?
|
| Aged | 6 | 2019 | 9620 | 0.160 |
Why?
|
| Child, Preschool | 1 | 2020 | 655 | 0.160 |
Why?
|
| Survival Analysis | 1 | 2019 | 310 | 0.160 |
Why?
|
| Hydrogels | 1 | 2017 | 9 | 0.150 |
Why?
|
| Tissue Adhesives | 1 | 2017 | 8 | 0.150 |
Why?
|
| Male | 8 | 2019 | 15877 | 0.150 |
Why?
|
| Dura Mater | 1 | 2017 | 21 | 0.140 |
Why?
|
| Exophthalmos | 1 | 2016 | 2 | 0.140 |
Why?
|
| Streptococcus milleri Group | 1 | 2016 | 2 | 0.140 |
Why?
|
| Neurosurgical Procedures | 2 | 2017 | 152 | 0.140 |
Why?
|
| Scalp | 1 | 2016 | 6 | 0.140 |
Why?
|
| Fourth Ventricle | 1 | 2016 | 1 | 0.140 |
Why?
|
| Diplopia | 1 | 2015 | 5 | 0.130 |
Why?
|
| Suction | 1 | 2016 | 41 | 0.130 |
Why?
|
| Parakeratosis | 1 | 2015 | 1 | 0.130 |
Why?
|
| Brain Neoplasms | 2 | 2015 | 134 | 0.130 |
Why?
|
| Pituitary Gland | 1 | 2015 | 9 | 0.130 |
Why?
|
| Renal Dialysis | 1 | 2016 | 111 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2016 | 83 | 0.130 |
Why?
|
| Postoperative Period | 1 | 2016 | 286 | 0.120 |
Why?
|
| Necrosis | 1 | 2014 | 27 | 0.120 |
Why?
|
| Laparotomy | 1 | 2014 | 22 | 0.120 |
Why?
|
| Cerebral Hemorrhage | 1 | 2016 | 131 | 0.120 |
Why?
|
| Device Removal | 1 | 2014 | 86 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 221 | 0.120 |
Why?
|
| Lymphoma | 1 | 2014 | 44 | 0.110 |
Why?
|
| Sinusitis | 1 | 2016 | 187 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2014 | 102 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 401 | 0.110 |
Why?
|
| Postoperative Complications | 2 | 2016 | 957 | 0.110 |
Why?
|
| Infant | 1 | 2014 | 542 | 0.110 |
Why?
|
| Radiography | 1 | 2014 | 678 | 0.100 |
Why?
|
| Middle Aged | 5 | 2019 | 9959 | 0.100 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2016 | 303 | 0.100 |
Why?
|
| Young Adult | 2 | 2017 | 1968 | 0.100 |
Why?
|
| Body Temperature | 1 | 2011 | 60 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 329 | 0.100 |
Why?
|
| Manikins | 1 | 2010 | 6 | 0.090 |
Why?
|
| Patient Simulation | 1 | 2010 | 7 | 0.090 |
Why?
|
| Neurosurgery | 1 | 2010 | 50 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2021 | 3325 | 0.090 |
Why?
|
| Adolescent | 1 | 2015 | 2335 | 0.090 |
Why?
|
| Critical Care | 1 | 2010 | 243 | 0.080 |
Why?
|
| Child | 2 | 2021 | 1379 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2003 | 159 | 0.060 |
Why?
|
| RNA, Neoplasm | 1 | 2003 | 15 | 0.060 |
Why?
|
| Meningioma | 1 | 2003 | 18 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2002 | 94 | 0.050 |
Why?
|
| Gene Expression | 1 | 2002 | 232 | 0.050 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 2021 | 5 | 0.050 |
Why?
|
| Petrous Bone | 1 | 2021 | 7 | 0.050 |
Why?
|
| Hearing Loss | 1 | 2019 | 11 | 0.040 |
Why?
|
| Pediatrics | 1 | 2019 | 33 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2019 | 332 | 0.040 |
Why?
|
| Valsalva Maneuver | 1 | 2017 | 4 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 4932 | 0.040 |
Why?
|
| Blood Coagulation Tests | 1 | 2014 | 12 | 0.030 |
Why?
|
| Rivaroxaban | 1 | 2014 | 8 | 0.030 |
Why?
|
| Dabigatran | 1 | 2014 | 7 | 0.030 |
Why?
|
| Antidotes | 1 | 2014 | 6 | 0.030 |
Why?
|
| Pyridones | 1 | 2014 | 14 | 0.030 |
Why?
|
| International Normalized Ratio | 1 | 2014 | 23 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 38 | 0.030 |
Why?
|
| Rituximab | 1 | 2014 | 54 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 53 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2014 | 53 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2014 | 154 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2014 | 50 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 379 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1856 | 0.030 |
Why?
|
| United States | 1 | 2017 | 2346 | 0.020 |
Why?
|
| Teaching | 1 | 2010 | 63 | 0.020 |
Why?
|
| Students, Medical | 1 | 2010 | 44 | 0.020 |
Why?
|
| Education, Medical | 1 | 2010 | 48 | 0.020 |
Why?
|
| Equipment Design | 1 | 2010 | 185 | 0.020 |
Why?
|
| Learning | 1 | 2010 | 80 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 2466 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2010 | 213 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 59 | 0.010 |
Why?
|
| Multigene Family | 1 | 2002 | 11 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2002 | 14 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 155 | 0.010 |
Why?
|
| Phenotype | 1 | 2003 | 363 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 285 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2003 | 644 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2003 | 491 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 401 | 0.010 |
Why?
|